There's now a $1 rival to Turing Pharmaceutical's $750 pill
One San Diego biomedical company is going to the opposite extreme of Turing Pharmaceuticals, which announced last month it planned to raise the cost of a generic drug used to treat toxoplasmosis from $13.50 a pill to $750.
Imprimis Pharmaceuticals said it will compete against other manufacturers that sell generic drugs way above cost, and will offer a drug to combat toxoplasmosis for $1 a capsule. In August, Turing acquired Daraprim, the brand-name formulation of pyrimethamine. Imprimis' version combines pyrimethamine with leucovorin, a form of folic acid that helps cancer patients undergoing chemotherapy. When explaining why Turing raised the price of Daraprim so drastically, Turing Pharmaceuticals CEO Martin Shkreli said the money would be used to fund research for new drugs (after a public outcry, the company said it would lower the cost).
Imprimis Pharmaceuticals CEO Mark L. Baum told The San Diego Union-Tribune Thursday that his company's response provides a market-based answer to prohibitive drug pricing. Imprimis uses ingredients that are FDA-approved and compounding operations that are FDA-inspected, but its formulations are not FDA-approved; filing for approval would take several years and cost millions, Baum said. Instead, the drugs are sold legally through doctor's prescriptions to specific patients. Imprimis is selling its compounded formulations of pyrimethamine and leucovorin for as low as $99 per bottle of 100 capsules, and Baum said that by not filing for FDA approval, the company can make a profit even when selling pills for less than $1 each. Imprimis has formed a division called Imprimis Cares, which will serve all 50 states with special formulations of high-priced generic drugs. "This is the tip of the iceberg," Baum said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
'New arrivals are more than paying for themselves'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
6 stylish homes in Portland, Oregon
Feature Featuring a wall of windows in Collins View and a historic ballroom in Portland Heights
By The Week US Published
-
What's next for US interest rates?
The Explainer Stubborn inflation forestalls anticipated rate cuts
By Becca Stanek, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published